Chemo or Not?
Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
Progress Against Cancer
Tumor profiling tests that predict the likelihood of distant recurrence can help some women with early-stage, hormone receptor-positive breast cancer decide on treatments after surgery.
The AACR Cancer Disparities Progress Report highlights the progress being made toward cancer health equity and stresses the need to address this complex public health issue.
Study finds racial disparities in the use of proton beam therapy, a focused treatment that can reduce side effects.
New studies probe how to match targeted therapies to children with cancer.
A magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
Study shows women have a higher risk of side effects from immunotherapy, adding to evidence that men and women react differently to treatment.
Genetic tests create opportunities but also confusion for breast cancer patients, and more from the week in cancer news.
Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
Cancer cells exploit an aging “infrastructure” to threaten life in those 60 and older.
The FDA granted accelerated approval to selpercatinib to treat solid tumors harboring RET gene fusions. The U.S. Food and Drug Administration (FDA) has granted accelerated approval to selpercatinib (Retevmo) for the treatment of adult...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More